Most Anticipated Trial Results Regarding Biomarkers in RCC

Most Anticipated Trial Results Regarding Biomarkers in RCC
Don Photo

Don
3 years 431 Views
Categorie:
Beschrijving:
Tian Zhang , MD, Assistant Professor of Medicine, Duke Cancer Institute, explains the anticipated trial results involving I-O, TKIs and biomarkers in renal cell carcinoma (RCC).